Association of cannabis potency with mental ill health and addiction: a systematic review

K Petrilli, S Ofori, L Hines, G Taylor, S Adams… - The Lancet …, 2022 - thelancet.com
Cannabis potency, defined as the concentration of Δ 9-tetrahydrocannabinol (THC), has
increased internationally, which could increase the risk of adverse health outcomes for …

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2024

Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD: THC ratios

A Englund, D Oliver, E Chesney, L Chester… - …, 2023 - nature.com
As countries adopt more permissive cannabis policies, it is increasingly important to identify
strategies that can reduce the harmful effects of cannabis use. This study aimed to determine …

Cannabis-related disorders and toxic effects

DA Gorelick - New England Journal of Medicine, 2023 - Mass Medical Soc
Cannabis-Related Disorders and Toxic Effects | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Prevalence of adolescent cannabis vaping: a systematic review and meta-analysis of US and Canadian studies

CCW Lim, T Sun, J Leung, JYC Chung… - JAMA …, 2022 - jamanetwork.com
Importance Vaping products were initially designed to deliver nicotine as a tobacco cigarette
substitute (eg, electronic cigarettes) but are now frequently used to deliver psychoactive …

Trends in the use of cannabis products in Canada and the USA, 2018–2020: Findings from the International Cannabis Policy Study

D Hammond, S Goodman, E Wadsworth… - International Journal of …, 2022 - Elsevier
Abstract Background and Aims There is little information on consumption patterns across the
diverse range of cannabis product types. This paper examines trends in consumption …

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use

V Lorenzetti, C Hindocha, K Petrilli, P Griffiths… - …, 2022 - Wiley Online Library
Background The lack of an agreed international minimum approach to measuring cannabis
use hinders the integration of multidisciplinary evidence on the psychosocial …

[HTML][HTML] Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research

SL Bourke, AK Schlag, SE O'Sullivan, DJ Nutt… - Pharmacology & …, 2022 - Elsevier
Characterised by chronic widespread musculoskeletal pain, generalised hyperalgesia, and
psychological distress, fibromyalgia (FM) is a significant unmet clinical need. The …

Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates

J Manthey, TP Freeman, C Kilian… - The Lancet Regional …, 2021 - thelancet.com
Background Cannabis is one of the most widely used substances worldwide. Heavy use is
associated with an increased risk of cannabis use disorders, psychotic disorders, acute …

Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis

T Schoeler, J Ferris, AR Winstock - Translational psychiatry, 2022 - nature.com
Cannabis, a widely used psychoactive substance, can trigger acute cannabis-associated
psychotic symptoms (CAPS) in people who use cannabis (PWUC). To assess rates and …